DuPont and SkyCell to collaborate on pharmaceutical temperature control

by Inside Logistics Online Staff
SkyCell specializes in temperature-controlled containers for food and pharmaceuticals

WILMINGTON, Delaware – DuPont Safety & Construction (DuPont), a business unit of DowDuPont Specialty Products Division and the manufacturer of DuPont Tyvek thermal cargo covers, and SkyCell, the Swiss-based manufacturer of temperature-controlled containers for food and pharmaceuticals, have announced a formal alliance to collaborate on technical and market development.

The partnership is expected to lead to innovations in: temperature monitoring, shipment tracking, asset management and ‘smart’ data-driven services. The combined effort is aimed at maintaining the physical and clinical integrity of pharmaceuticals in transit.

“DuPont is a firm believer in the potential of strategic alliances like this one where each party can leverage its respective strength for powerful solutions,” said Christian Marx, vice-president and general manager of Tyvek and Typar.

“There is a strong strategic fit between DuPont and SkyCell and we see this as an important step in complementing our Tyvek Cargo Covers offering and expanding our market capability with high-performance solutions for an increasingly sophisticated pharmaceutical supply chain.”

Under the terms of the agreement DuPont will gain access to SkyCell’s remote temperature-management solutions and expertise and acquire marketing rights to the SkyCell portfolio of insulated shipping containers. The SkyCell containers will be marketed by DuPont alongside its Tyvek products.

SkyCell, on the other hand, will be in a position to tap into the renowned technical resource of DuPont and will benefit from the DuPont global network especially in emerging markets and the Asia-Pacific region.

“We are excited to be entering into the next stage of our journey by collaborating with DuPont Tyvek, a trusted provider of protection in pharmaceutical logistics,” said Richard Ettl, CEO of SkyCell.

“With a shared vision of better leveraging data in the supply chain of sensitive pharmaceuticals, this partnership will help us play our part in ensuring that medicines, vaccines and other health-related treatments get to the final patients in a safe, sustainable and timely manner.”